ESH Video

#ESHMDS2024 LIGHT UPON THE LEARNING OBJECTIVES

October 10, 2023

 

9th Translational Research Conference
MYELODYSPLASTIC SYNDROMES

 

Save the date: April 12-14, 2024

Budapest, Hungary - #ESHMDS2024

 

 


 

CONFERENCE LEARNING OBJECTIVES:


Upon completion of this CME activity, participants should:
• Learn how to optimally diagnose MDS, mainly by morphological analysis and cytogenetics, but also through the use of new tools, mainly molecular analysis

• Improve ability to analyse prognostic factors, including new ones
(revised IPSS, molecular analysis)

• Review current treatment of MDS, in both the high risk and low risk settings,
ranging from single follow up to allogeneic stem cell transplantation

• Acquire improved knowledge of emerging treatments,
based on targeted therapies and well conducted clinical trials

 

Join us in Budapest:

 

 

 

 

 



About the Conference:

 

The ESH 9th Translational Research Conference on MYELODYSPLASTIC SYNDROMES proposes a programme of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field.

It is open to an international audience of biologists and clinicians, including those still in-training. This translational research conference will bring together biologists and clinicians with an interest in Myelodysplastic Syndromes (MDS) in order to explore the most recent advances in the understanding of the pathogenesis and clinical behavior of the disease.

New data will be presented on how to best apply these insights to the future of MDS therapy. Diagnostic, prognostic and therapeutic issues will be presented by the faculty and ample time will be devoted to discussion with delegates.

 


 

Abstract submission for oral or poster presentation is OPEN!
Deadline: January 15th, 2024

 

 


 

THE PROGRAMME WILL INCLUDE:
Plenary Sessions - Panel Discussions - Roundtables
Simultaneous Meet the Expert Sessions
Poster Walks - Brief Oral Communications


 

CLICK HERE FOR MORE INFORMATION